Comprehensive Review of Hypogammaglobulinemia and Infection Rates in MS Patients Treated with Anti-CD20 Antibodies (P8-1.007)
To investigate the relationship between anti-CD20 treatments in Multiple Sclerosis (MS), serum immunoglobulin G (IgG) levels, and the risk of hypogammaglobulinemia and infections, aiming to inform treatment strategies to prevent severe infections.
Authors
- Lobna A. Mohamed (ORCID: https://orcid.org/0000-0001-5429-097X)
- Omar Alomarı (ORCID: https://orcid.org/0000-0003-3651-4129)
- Anas Elgenidy (ORCID: https://orcid.org/0000-0002-4532-8574)
- Mohammed Al‐mahdi Al‐kurdi (ORCID: https://orcid.org/0000-0002-1858-8450)
- Mohammed M. Ghoneim (ORCID: https://orcid.org/0000-0002-9179-4373)
- Nagham Nader Abdelhalim
- Hazem Khaled Hassaan (ORCID: https://orcid.org/0009-0003-9868-3232)
- Ahmed Wagdy Fathy
- Ahmed Anan
Institutions
- University of Aleppo (SY)
- Suez Canal University (EG)
- Kafrelsheikh University (EG)
- Cairo University (EG)
- Benha University (EG)
- Sağlık Bilimleri Üniversitesi (TR)
- Menoufia University (EG)
- Alexandria University (EG)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211418
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00